These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3481088)

  • 1. Assessment of dopaminergic function in children and adults: long and brief debrisoquin administration combined with plasma homovanillic acid.
    Riddle MA; Leckman JF; Anderson GM; Hardin MT; Ort SI; Towbin KE; Shaywitz BA; Cohen DJ
    Psychopharmacol Bull; 1987; 23(3):411-4. PubMed ID: 3481088
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of debrisoquin on plasma homovanillic acid concentration in schizophrenic patients.
    Davidson M; Losonczy MF; Mohs RC; Powchick P; Freed LB; Kaminsky R; Davis KL
    Psychopharmacol Bull; 1987; 23(3):407-10. PubMed ID: 3432512
    [No Abstract]   [Full Text] [Related]  

  • 3. Brief debrisoquin administration to assess central dopaminergic function in children.
    Riddle MA; Shaywitz BA; Leckman JF; Anderson GM; Shaywitz SE; Hardin MT; Ort SI; Cohen DJ
    Life Sci; 1986 Mar; 38(11):1041-8. PubMed ID: 3456480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of central dopaminergic function using plasma-free homovanillic acid after debrisoquin administration.
    Riddle MA; Leckman JF; Cohen DJ; Anderson M; Ort SI; Caruso KA; Shaywitz BA
    J Neural Transm; 1986; 67(1-2):31-43. PubMed ID: 3465864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of debrisoquin and haloperidol on plasma homovanillic acid concentration in schizophrenic patients.
    Davidson M; Losonczy MF; Mohs RC; Lesser JC; Powchik P; Freed LB; Davis BM; Mykytyn VV; Davis KL
    Neuropsychopharmacology; 1987 Dec; 1(1):17-23. PubMed ID: 3509064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma debrisoquin levels in the assessment of reduction of plasma homovanillic acid. The debrisoquin method.
    Riddle MA; Jatlow PI; Anderson GM; Cho SC; Hardin MT; Cohen DJ; Leckman JF
    Neuropsychopharmacology; 1989 Jun; 2(2):123-9. PubMed ID: 2742727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catecholamine metabolites in human plasma as indices of brain function: effects of debrisoquin.
    Swann AC; Maas JW; Hattox SE; Landis H
    Life Sci; 1980 Nov; 27(20):1857-62. PubMed ID: 7193269
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of debrisoquin on CSF and plasma HVA concentrations in man.
    Maas JW; Contreras SA; Bowden CL; Weintraub SE
    Life Sci; 1985 Jun; 36(22):2163-70. PubMed ID: 3999921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic dsyfunction in Tourette syndrome.
    Singer HS; Butler IJ; Tune LE; Seifert WE; Coyle JT
    Ann Neurol; 1982 Oct; 12(4):361-6. PubMed ID: 6184010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in human urine homovanillic acid concentration after neuroleptic treatment is the same with or without debrisoquin administration.
    Contreras SA; Maas JW; Seleshi E; Bowden CL
    Arch Gen Psychiatry; 1987 Dec; 44(12):1109-10. PubMed ID: 3689099
    [No Abstract]   [Full Text] [Related]  

  • 11. Tolerance and side effects during long term treatment of hypertension with debrisoquine.
    Jackson WB
    Aust N Z J Med; 1972 Nov; 2(4):357-65. PubMed ID: 4144623
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma-free homovanillic acid: within- and across-day stability in children and adults with Tourette's syndrome.
    Riddle MA; Leckman JF; Anderson GM; Ort SI; Hardin MT; Stevenson J; Cohen DJ
    Life Sci; 1987 Jun; 40(22):2145-51. PubMed ID: 3473273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New sympathoplegic antihypersensive agent: debrisoquin sulfate].
    Biron P
    Union Med Can; 1973 May; 102(5):1134-5. PubMed ID: 4712043
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma homovanillic acid profile at different phases of the ovulatory cycle in healthy women.
    Abel KM; O'Keane V; Sherwood RA; Murray RM
    Biol Psychiatry; 1996 Jun; 39(12):1039-43. PubMed ID: 8780839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma homovanillic acid differences in clinical subgroups of first episode schizophrenic patients.
    Baeza I; Castro-Fornieles J; Deulofeu R; de la Serna E; Goti J; Salvà J; Bernardo M
    Psychiatry Res; 2009 Jul; 168(2):110-8. PubMed ID: 19501918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma homovanillic acid and the dopamine transporter during cocaine withdrawal.
    Bowers MB; Malison RT; Seibyl JP; Kosten TR
    Biol Psychiatry; 1998 Feb; 43(4):278-81. PubMed ID: 9513737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of blood-pressure during chronic administration of postganglionic sympathetic blocking drugs for hypertension.
    Goldberg AD; Raftery EB
    Lancet; 1976 Nov; 2(7994):1052-4. PubMed ID: 62901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic results with the hypotensive agent Declinax (debrisoquin) in mild and medium forms of hypertension].
    Bückert A; Schweda E; Vich V
    Schweiz Rundsch Med Prax; 1973 Nov; 62(47):1453-60. PubMed ID: 4202234
    [No Abstract]   [Full Text] [Related]  

  • 19. Total ischaemia at site of local anaesthesia in patient on debrisoquine.
    French AJ; Patel YV
    Lancet; 1980 Aug; 2(8192):484-5. PubMed ID: 6106132
    [No Abstract]   [Full Text] [Related]  

  • 20. Tics and Tourette syndrome.
    Singer HS
    Johns Hopkins Med J; 1982 Jul; 151(1):30-5. PubMed ID: 6953280
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.